Pteridine derivatives with nitric oxide synthase inhibitor function

A compound, pteridine technology, applied in the field of pteridine derivatives, can solve the problem of lack of NOS isomerase inhibitory selectivity

Inactive Publication Date: 2004-11-17
CHINA PHARM UNIV
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Inhibitors mentioned above lack considerable selectivity for NOS isomerase inhibition

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pteridine derivatives with nitric oxide synthase inhibitor function
  • Pteridine derivatives with nitric oxide synthase inhibitor function
  • Pteridine derivatives with nitric oxide synthase inhibitor function

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0088] 1. Compound preparation

[0089] 2-amino-4-[N-(ethyl p-aminobenzoate)-yl]-6-phenylpteridine ( 6 )

[0090] 0.68g (1.65mmol) compound A (wherein: NR 2 R 3 = HNC 6 h 4 COOC 2 h 5 ) was added into 15 mL of anhydrous methanol to dissolve it completely, and under the conditions of nitrogen protection, stirring and oil bath reflux, dropwise added a solution composed of benzoxime (C, R”=H) 0.37 g (2.48 mmol) and 6 mL of methanol , reflux reaction for 4 hours, stop heating, and after cooling to room temperature, adjust the pH value to 7-8 with ammonia water, solids precipitated, put it in the refrigerator overnight, and filtered to obtain the crude product, which was recrystallized from a mixture of ether and ethanol to obtain 0.22 g of orange-yellow solid 6 , Yield: 34.6%, m.p.275~277℃. 1 H-NMRδ: 9.32 (s, 1H, 7-H), 9.23 (s, 1H, 4-NH), 8.13-7.97 (m, 6H, Ph-H), 7.55 (m, 3H, Ph-H), 6.06 (bs, 2H, 2-NH 2 ), 4.39 (q, J=6.9Hz, 2H, CH 2 ), 1.41(t, J=6.9Hz, 3H, CH 3 ).ESI-M...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates a novel pteridine derivative with formula (I), which is a NO synthetase, in particular the suppressant for evoked type NO synthetase, which can be used in the prevention and treatment of diseases caused by NO level rise.

Description

technical field [0001] The present invention relates to the design and synthesis of pteridine derivatives capable of controlling excessive production of nitric oxide free radicals (NO·, abbreviated as NO) in the body, especially pteridine derivatives with the effect of inducible NO synthase inhibitors. Medicines for preventing and treating diseases mediated by elevated NO levels in the body can be prepared. [0002] This invention research work was funded by the National Natural Science Foundation of China (Project No. 39870822). Background of the invention [0003] NO is a bioactive molecule with low molecular weight and hydrophobic properties, which can freely pass through the cell membrane and act on target molecules in the cell. Theoretically, NO can reach any part of the cell and tissue, so it can regulate various cell functions and Produce a wide range of biological effects. NO is produced by endogenous nitric oxide synthase (NO Synthase, abbreviated as NOS). NOS use...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/519A61P3/10A61P7/00A61P9/00A61P25/06A61P25/08A61P29/00A61P37/06C07D475/08
Inventor 姚其正王秋娟吕刚周卫芬唐锋毛利姆
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap